HBM Partners Overview
- Investor Type
-
Venture Capital
- Status
-
Active
- Professionals
-
5
- Investments
-
194
- Portfolio
-
28
- Exits
-
139
HBM Partners General Information
Company Description
Founded in 2001, HBM Partners is a venture capital firm based in Zug, Switzerland. The firm prefers to invest in companies operating in the biopharma and healthcare sectors, with a focus on those based in Europe, North America, and India.
Business Details
Website
www.hbmpartners.comYear Founded
Investor Status
Trade Association
Primary Investor Type
Other Investor Types
Corporate Office
- Bundesplatz 1
- 6300 Zug
- Switzerland
HBM Partners Investments (194)
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Company Stage | Lead Partner |
|---|---|---|---|---|---|---|
| Lytica | 29-Sep-2026 | Later Stage VC | Drug Discovery | Pre-Clinical Trials | ||
| Crystalys Therapeutics | 30-Sep-2025 | Drug Discovery | Clinical Trials - Phase 3 | |||
| Neoscience (Biotechnology) | 01-Jun-2025 | Biotechnology | Generating Revenue | |||
| Numab Therapeutics | 09-Jan-2025 | Drug Discovery | Clinical Trials - Phase 2 | |||
| Xcell Biosciences | 17-Dec-2024 | Discovery Tools (Healthcare) | Generating Revenue | |||
| Shape Memory Medical | 16-Dec-2024 | Therapeutic Devices | Generating Revenue | |||
| Biopas Group | 31-May-2024 | Pharmaceuticals | Generating Revenue | |||
| Alumis (United States) | 29-May-2024 | Drug Discovery | Generating Revenue | |||
| Hausen Bernstein | 01-Mar-2024 | Buyout/LBO | Distributors/Wholesale | Generating Revenue | ||
| ADARx Pharmaceuticals | 02-Aug-2023 | Later Stage VC | Drug Discovery | Generating Revenue/Not Profitable |
HBM Partners Exits (139)
| Company Name | Exit Date | Exit Type | Exit Size |
|---|---|---|---|
| ADARx Pharmaceuticals | 25-Sep-2026 | IPO | |
| Freenome | 20-Jul-2026 | ||
| Parabilis Medicines | 10-Jun-2026 | ||
| Swixx Biopharma | 01-Jun-2026 | ||
| Odyssey Therapeutics | 07-May-2026 | ||
| connectRN | 20-Apr-2026 | ||
| AtaiBeckley | 20-Oct-2025 | ||
| Aculys | 15-Oct-2025 | ||
| Trace Genomics | 07-Jul-2025 | Merger/Acquisition | |
| Visen Pharmaceuticals | 21-Mar-2025 | IPO |
HBM Partners Fund Performance
| Fund Name | Vintage | Size | Dry Powder | DPI | RVPI | TVPI | IRR |
|---|
HBM Partners Investments by Industry, Year, and Region
Investments by Industry
Investments by Year
Investments by Region
HBM Partners Co-Investors (109)
| Name | With | Exits | Lead Partner | Series | Industry |
|---|---|---|---|---|---|
| HBM Healthcare Investments | 12 |
|
|
||
| OrbiMed |
|
|
|||
| Cormorant Asset Management |
|
|
|||
| LAV (Lilly Asia Fund) |
|
|
|||
| SR One |
|
|
HBM Partners Affiliates
Subsidiaries (1)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| HBM Healthcare Investments | Zug, Switzerland | 2001 |
HBM Partners FAQs
-
What is HBM Partners?
Founded in 2001, HBM Partners is a venture capital firm based in Zug, Switzerland.
-
When was HBM Partners founded?
HBM Partners was founded in 2001.
-
Where is HBM Partners headquartered?
HBM Partners is headquartered in Zug, Switzerland.
-
What is HBM Partners's total asset value?
HBM Partners has around in total assets under management.
-
How many investments has HBM Partners made?
HBM Partners has made 194 investments.
-
What has HBM Partners invested in?
HBM Partners has made numerous investments in companies like Lytica, Crystalys Therapeutics, and Neoscience (Biotechnology) within the Drug Discovery and Biotechnology industries.
-
What has HBM Partners invested in recently?
HBM Partners's latest investment was on 29-Sep-2026 in Lytica, a company within the Drug Discovery industry.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
